UBS Group AG - HISTOGENICS CORP ownership

HISTOGENICS CORP's ticker is HSGX and the CUSIP is 43358V109. A total of 25 filers reported holding HISTOGENICS CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of HISTOGENICS CORP
ValueSharesWeighting
Q2 2019$0
-100.0%
1,500
-95.7%
0.00%
Q1 2019$4,000
-55.6%
34,904
-65.8%
0.00%
Q4 2018$9,000
+800.0%
101,911
+6694.1%
0.00%
Q3 2018$1,000
-92.3%
1,500
-69.5%
0.00%
Q2 2018$13,000
+225.0%
4,920
+228.0%
0.00%
Q1 2018$4,000
-42.9%
1,500
-55.8%
0.00%
Q4 2017$7,000
-50.0%
3,392
-57.2%
0.00%
Q2 2017$14,000
-26.3%
7,922
-26.6%
0.00%
Q1 2017$19,000
+375.0%
10,798
+370.7%
0.00%
Q4 2016$4,000
-55.6%
2,294
-1.1%
0.00%
Q3 2015$9,0002,319
+15360.0%
0.00%
Q1 2015$0
-100.0%
15
-98.6%
0.00%
Q4 2014$12,0001,0460.00%
Other shareholders
HISTOGENICS CORP shareholders Q1 2017
NameSharesValueWeighting ↓
Sofinnova Management VIII, L.L.C. 2,077,040$3,469,0001.95%
Abingworth LLP 888,889$1,440,0001.20%
ARMISTICE CAPITAL, LLC 1,264,000$2,111,0000.50%
Third Security, LLC 2,690,570$4,493,0000.24%
Perceptive Advisors 1,777,777$2,968,0000.21%
CARL DOMINO INC 87,000$145,0000.16%
SABBY MANAGEMENT, LLC 944,891$1,578,0000.09%
Palo Alto Investors LP 302,922$506,0000.03%
PURA VIDA INVESTMENTS, LLC 13,526$23,0000.01%
Virtu KCG Holdings LLC 14,764$25,0000.00%
View complete list of HISTOGENICS CORP shareholders